Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA appropriations

This article was originally published in The Gray Sheet

Executive Summary

House-Senate conference committee approves bill to fund FDA through fiscal 2010, including $2.36 billion in appropriations, on Sept. 30. The total is $306 million more than 2009 funding and $7 million more than the president requested. The bill also approves the collection of $893 million in industry user fees. Medical device activities will get $349.3 million in appropriations under the bill, plus $57 million in user fees. The conference agreement still needs approval by the full House and Senate, and the president's signature. The government will be funded at fiscal 2009 levels though Oct. 31 under a continuing resolution

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027992

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel